From AI to Musk’s Brain Chip, the F.D.A.’s Device Unit Faces Rapid Changenews2024-11-01T23:57:56+00:00November 1st, 2024|The New York Times|
What Drugmakers Did Not Tell Volunteers in Alzheimer’s Trialsnews2024-10-23T14:19:56+00:00October 23rd, 2024|The New York Times|
Embattled Alzheimer’s Researcher Is Charged With Fraudnews2024-06-28T22:05:18+00:00June 28th, 2024|The New York Times|
David Egilman, Doctor Who Took On Drug Companies, Dies at 71news2024-04-15T21:59:12+00:00April 15th, 2024|The New York Times|
‘What’s My Life Worth?’ The Big Business of Denying Medical Carenews2024-03-15T14:28:40+00:00March 15th, 2024|The New York Times|
Scientists Investigating Alzheimer’s Drug Faulted in Leaked Reportnews2023-10-14T17:25:41+00:00October 14th, 2023|The New York Times|
Research Trials Halted at Columbia’s Psychiatric Center After Suicidenews2023-08-10T20:28:21+00:00August 10th, 2023|The New York Times|
Biogen Agrees to Pay $900 Million to Settle Lawsuit Over Kickbacksnews2022-09-27T00:35:45+00:00September 27th, 2022|The New York Times|
Supreme Court Hears Case of Doctors Accused of Running Pill Millsnews2022-03-01T21:52:28+00:00March 1st, 2022|The New York Times|